DILUENT-2-DOSE
DEAD

Serial Number

87011650

Owner

Asepsis Medical Technologies, LLC

Filing Date

Apr 23, 2016

Add to watchlist:

No watchlists yet
View on USPTO

DILUENT-2-DOSE Trademark

Serial Number: 87011650

DILUENT-2-DOSE is a trademark filed by Asepsis Medical Technologies, LLC on April 23, 2016. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Asepsis Medical Technologies, LLC (5 trademarks)

Sarasota, FL 34234

Entity Type: 16

Trademark Details

Filing Date

April 23, 2016

Registration Date

Not Registered

Goods & Services

Anti-infectives; antiemetics; cardiovascular pharmaceuticals; dermatological pharmaceutical products; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; ocular pharmaceuticals; pharmaceutical anti-allergic preparations and substances; pharmaceutical antitussive-cold preparations; pharmaceutical preparation for the treatment of gout; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; pharmaceutical preparations for ocular or intraocular surgery; pharmaceutical preparations for skin care; pharmaceutical preparations for the treatment and prevention of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for wounds; pharmaceutical products for ophthalmological use; potassium preparations for pharmaceutical purposes; vitamin and mineral preparations for medical use

Filing History

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Mar 9, 2017 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Mar 9, 2017 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 9, 2016 GNRN
NON-FINAL ACTION E-MAILED
Aug 9, 2016 GNRT
NON-FINAL ACTION WRITTEN
Aug 9, 2016 CNRT
ASSIGNED TO EXAMINER
Aug 9, 2016 DOCK
NOTICE OF PSEUDO MARK E-MAILED
Apr 28, 2016 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 27, 2016 NWOS
NEW APPLICATION ENTERED
Apr 27, 2016 NWAP